SEC Tracker
Get the app

Evommune EVMN

Evommune: Ownership stake disclosure (amended)

Schedule 13D/A on Evommune (EVMN), filed with the SEC on Nov 10, 2026, 4:46 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. RA Capital Management, L.P. and others hold 2,710,293 shares directly.
  2. RA Capital Healthcare Fund, L.P. holds 784,345 shares directly.
  3. Total shares outstanding as of August 4, 2026, was 36,292,113.
  4. Private placement added 4,966,889 shares as of November 6, 2026.

Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Evommune files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.